Cargando…

RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19

Detalles Bibliográficos
Autores principales: Bombonatti, J.F., Carvalho, L.M., Loss, S.R., Langhi, M.M., Abdo, A.R.N., Bordin, J.O., Baiocchi, O.C.G., Filho, J.P.Z., Menezes, Y., Bachour, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2020
Materias:
456
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604196/
http://dx.doi.org/10.1016/j.htct.2020.10.458
_version_ 1783604091412283392
author Bombonatti, J.F.
Carvalho, L.M.
Loss, S.R.
Langhi, M.M.
Abdo, A.R.N.
Bordin, J.O.
Baiocchi, O.C.G.
Filho, J.P.Z.
Menezes, Y.
Bachour, P.
author_facet Bombonatti, J.F.
Carvalho, L.M.
Loss, S.R.
Langhi, M.M.
Abdo, A.R.N.
Bordin, J.O.
Baiocchi, O.C.G.
Filho, J.P.Z.
Menezes, Y.
Bachour, P.
author_sort Bombonatti, J.F.
collection PubMed
description
format Online
Article
Text
id pubmed-7604196
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Editora Ltda.
record_format MEDLINE/PubMed
spelling pubmed-76041962020-11-02 RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19 Bombonatti, J.F. Carvalho, L.M. Loss, S.R. Langhi, M.M. Abdo, A.R.N. Bordin, J.O. Baiocchi, O.C.G. Filho, J.P.Z. Menezes, Y. Bachour, P. Hematol Transfus Cell Ther 456 Published by Elsevier Editora Ltda. 2020-11 2020-10-31 /pmc/articles/PMC7604196/ http://dx.doi.org/10.1016/j.htct.2020.10.458 Text en Copyright © 2020 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 456
Bombonatti, J.F.
Carvalho, L.M.
Loss, S.R.
Langhi, M.M.
Abdo, A.R.N.
Bordin, J.O.
Baiocchi, O.C.G.
Filho, J.P.Z.
Menezes, Y.
Bachour, P.
RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title_full RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title_fullStr RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title_full_unstemmed RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title_short RECAÍDA ATÍPICA DE MIELOMA MÚLTIPLO ASSOCIADA AO USO DE TOCILIZUMABE PARA COVID -19
title_sort recaída atípica de mieloma múltiplo associada ao uso de tocilizumabe para covid -19
topic 456
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604196/
http://dx.doi.org/10.1016/j.htct.2020.10.458
work_keys_str_mv AT bombonattijf recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT carvalholm recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT losssr recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT langhimm recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT abdoarn recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT bordinjo recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT baiocchiocg recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT filhojpz recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT menezesy recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19
AT bachourp recaidaatipicademielomamultiploassociadaaousodetocilizumabeparacovid19